v3.25.1
Stock Options
 3 Months Ended
Mar. 31, 2025
Stock Options [Abstract]  
STOCK OPTIONS

13. STOCK OPTIONS

 

The Company has not granted any options during three months ended March 31, 2025 and 2024. The Company’s most recent option grant was in 2022 that 76,190 shares (post-split) of common stock were granted to employees and certain consultants. The weighted average grant date fair value of options granted in 2022 was $27.9 (post-split). There are 386,021 options available for grant under the 2016 Equity Incentive Plan as of December 31, 2024. Compensation costs associated with the Company’s stock options are recognized, based on the grant-date fair values of these options over vesting period. As of March 31, 2025 and December 31, 2024, there were no unvested options.

 

Options issued and outstanding as of March 31, 2025, and their activities during the year then ended are as follows:

 

       Weighted-   Weighted-     
       Average   Average     
   Number of   Exercise   Contractual     
   Underlying
Shares
(post-split)		   Price
Per Share
(post-split)		   Life
Remaining
in Years		   Aggregate
Intrinsic
Value		 
Outstanding as of January 1, 2025   258,710   $27.9    6.74    
     -
 
Granted   
-
    
-
    -    
-
 
Forfeited   
-
    
-
    -    
-
 
Outstanding as of March 31, 2025   258,710    27.9    6.50   $
-
 
Exercisable as of March 31, 2025   258,710    27.9    6.50   $
-
 
Vested and expected to vest   258,710   $27.9    6.50   $
-